Head and Neck Squamous Cell Cancer Clinical Trials

23 clinical trials for Head and Neck Squamous Cell Cancer across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC — RECRUITING · PHASE1
• Study of XB010 in Subjects With Solid Tumors — RECRUITING · PHASE1
• A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 — RECRUITING · PHASE1
• Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer — RECRUITING · PHASE1
• A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression — RECRUITING · PHASE1
• A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED) — NOT_YET_RECRUITING · PHASE2
• A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer — COMPLETED · PHASE1
• A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719 — COMPLETED · NA
• A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands — COMPLETED · PHASE1
• Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling — COMPLETED · PHASE1
• Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer — COMPLETED · PHASE1
• LITT and Pembrolizumab in Recurrent Brain Metastasis — TERMINATED · PHASE1
• Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040) — COMPLETED · PHASE3
• Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC) — COMPLETED · PHASE1
• Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma — COMPLETED · PHASE1
• Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer — TERMINATED · PHASE2
• Sintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma ) — OTHER · PHASE2
• LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer — TERMINATED · PHASE2
• Safety Study of Modified Vaccinia Virus to Cancer — COMPLETED · PHASE1
• Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer — OTHER · PHASE3
• Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer — TERMINATED · NA
• Intensive Nutrition Counselling in Patients With Head and Neck Cancer — OTHER · NA
• Head and Neck Cancer Screening and Serum Repository — COMPLETED

Refine this search